Acro Biomedical (ACBM) Non-Current Assets (2017 - 2025)
Acro Biomedical's quarterly Non-Current Assets came in at $13651.0 in Q2 2025, down 69.22% year-on-year from $44355.0 in Q2 2024, and down 32.83% quarter-over-quarter from $20324.0 in Q1 2025.
Acro Biomedical has reported Non-Current Assets for 9 years, with the latest figure at $13651.0 in Q2 2025.
- For the quarter ending Q2 2025, Non-Current Assets fell 69.22% year-over-year to $13651.0; the trailing twelve-month figure through Dec 2025 stood at $33975.0 (down 78.75% YoY), and the FY2024 full-year result was $26898.0, down 52.67% from the prior year.
- Non-Current Assets for Q2 2025 stood at $13651.0, down from $20324.0 in the prior quarter.
- The five-year high for Non-Current Assets was $56833.0 in Q4 2023, with the low at $6268.0 in Q3 2021.
- Average Non-Current Assets over 5 years is $29931.8, with a median of $28423.5 recorded in 2022.
- Year-over-year, Non-Current Assets slumped 82.07% in 2021 and surged 481.9% in 2024.
- Tracing ACBM's Non-Current Assets over 5 years: stood at $54662.0 in 2021, then plunged by 45.21% to $29949.0 in 2022, then surged by 89.77% to $56833.0 in 2023, then plunged by 52.67% to $26898.0 in 2024, then plunged by 49.25% to $13651.0 in 2025.
- The last three Non-Current Assets figures came in at $13651.0 (Q2 2025), $20324.0 (Q1 2025), and $26898.0 (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | EQV Ventures Acquisition | 477.69 Mn | 477.69 Mn | - | 472.84 Mn |
| 2 | Berto Acquisition | 316.66 Mn | 316.66 Mn | - | 311.36 Mn |
| 3 | Centurion Acquisition | 311.94 Mn | 311.94 Mn | - | 310.90 Mn |
| 4 | Churchill Capital Corp IX | 311.36 Mn | 311.36 Mn | - | 310.26 Mn |
| 5 | Agriculture & Natural Solutions Acquisition | 301.94 Mn | 301.94 Mn | - | 365.97 Mn |
| 6 | Siddhi Acquisition Corp (Cayman Islands) | 286.76 Mn | 286.76 Mn | - | 288.44 Mn |
| 7 | Bold Eagle Acquisition | 276.06 Mn | 276.06 Mn | - | 272.15 Mn |
| 8 | Cartesian Growth Corp III | 270.68 Mn | 270.68 Mn | - | 285.88 Mn |
| 9 | Oyster Enterprises II Acquisition | 266.84 Mn | 266.84 Mn | - | 261.51 Mn |
| 10 | Acro Biomedical | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 13,651.00 |
| Mar 31, 2025 | 20,324.00 |
| Dec 31, 2024 | 26,898.00 |
| Sep 30, 2024 | 37,975.00 |
| Jun 30, 2024 | 44,355.00 |
| Mar 31, 2024 | 50,641.00 |
| Dec 31, 2023 | 56,833.00 |
| Sep 30, 2023 | 6,526.00 |
| Jun 30, 2023 | 12,988.00 |
| Mar 31, 2023 | 19,385.00 |
| Dec 31, 2022 | 29,949.00 |
| Sep 30, 2022 | 36,220.00 |
| Jun 30, 2022 | 42,429.00 |
| Mar 31, 2022 | 48,576.00 |
| Dec 31, 2021 | 54,662.00 |
| Sep 30, 2021 | 6,268.00 |
| Jun 30, 2021 | 12,474.00 |
| Mar 31, 2021 | 18,618.00 |
| Dec 30, 2020 | 24,700.00 |
| Sep 30, 2020 | 34,951.00 |
| Jun 30, 2020 | 40,912.00 |
| Mar 31, 2020 | 46,813.00 |
| Dec 31, 2019 | 52,655.00 |
| Jun 30, 2019 | 9,871.00 |
| Mar 31, 2019 | 65,065.00 |
| Dec 31, 2018 | 19,941.00 |
| Sep 30, 2018 | 4,992.00 |
| Jun 30, 2018 | 4,992.00 |
| Mar 31, 2018 | 4,992.00 |
| Dec 31, 2017 | 4,992.00 |